Showing results (1331-1340 of 1,351) with videos related to
Sort By:
Pageof 136
Cancer Cell|May 16, 2019
BCL2 Amplicon Loss and Transcriptional Remodeling Drives ABT-199 Resistance in B Cell Lymphoma ModelsXiaohong Zhao, Yuan Ren, Matthew Lawlor, et al.Cancer Discovery|November 13, 2021
EP300 Selectively Controls the Enhancer Landscape of MYCN-Amplified NeuroblastomaAdam D Durbin, Tingjian Wang, Virangika K Wimalasena, et al.Gynecologic Oncology|September 21, 2023
Effectiveness and safety of REBACIN as a non-invasive intervention for persistent high-risk human papillomavirus infection: A real-world prospective multicenter cohort studyFei Chen, Guo-Nan Zhang, Wei Lei, et al.Cancer Science|July 16, 2011
Systematic confirmation study of reported prostate cancer risk-associated single nucleotide polymorphisms in Chinese menFang Liu, Ann W Hsing, Xiang Wang, et al.Cancer Discovery|August 23, 2020
The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting TherapiesAngela Su, Frank Ling, Camille Vaganay, et al.Carcinogenesis|November 25, 2011
Replication and cumulative effects of GWAS-identified genetic variations for prostate cancer in Asians: a case-control study in the ChinaPCa consortiumMeilin Wang, Fang Liu, Ann W Hsing, et al.Cancer Discovery|June 18, 2016
Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung CancerHaikuo Zhang, Jun Qi, Jaime M Reyes, et al.Nature Medicine|May 13, 2024
Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancerYue Zeng, Chun-Hong Hu, Yi-Zheng Li, et al.The Journal of Clinical Investigation|December 5, 2017
CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2Liying Chen, Gabriela Alexe, Neekesh V Dharia, et al.The Prostate|June 22, 2012
A novel germline mutation in HOXB13 is associated with prostate cancer risk in Chinese menXiaoling Lin, Lianxi Qu, Zhuo Chen, et al.Pageof 136